{"transactions":[{"id":671694,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18221,"kind":"person","name":"Luther Sanjeev","position":1,"cik":"0001933592","reported_name":"Luther Sanjeev","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-02T01:46:29.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":118848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":118848,"derivative":{"exercise_price":4.57,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":118848},"source":{"system":"sec-edgar","filing":"0001493152-26-041130","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315226041130/ownership.xml","form_type":"4"}},{"id":1278030,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18221,"kind":"person","name":"Luther Sanjeev","position":1,"cik":"0001933592","reported_name":"Luther Sanjeev","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-11T00:00:07.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":1123350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":1123350,"derivative":{"exercise_price":0.34,"expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":1123350},"source":{"system":"sec-edgar","filing":"0001493152-25-005718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315225005718/ownership.xml","form_type":"4"}},{"id":1695459,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18221,"kind":"person","name":"Luther Sanjeev","position":1,"cik":"0001933592","reported_name":"Luther Sanjeev","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:02:56.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":1685218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, 25% of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 36 substantially equal monthly installments thereafter."}],"balance_after":1685218,"derivative":{"exercise_price":1.8,"expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.005 per share","underlying_shares":1685218},"source":{"system":"sec-edgar","filing":"0001140361-24-000469","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036124000469/form4.xml","form_type":"4"}}]}